CVS Health Q3 2021 Earnings Report
Key Takeaways
CVS Health reported strong Q3 2021 results with total revenues increasing to $73.8 billion, GAAP diluted EPS of $1.20, and adjusted EPS of $1.97.
Total revenues increased to $73.8 billion, up 10.0% compared to prior year
GAAP diluted EPS of $1.20, up 29.0% compared to prior year
Adjusted EPS of $1.97, up 18.7% compared to prior year
Administered more than 8 million COVID-19 tests and more than 11 million COVID-19 vaccines nationwide in the third quarter.
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
The Company revised its full year 2021 GAAP diluted EPS guidance range to $6.13 to $6.23 from $6.35 to $6.45, raised its full year 2021 Adjusted EPS guidance range to $7.90 to $8.00 from $7.70 to $7.80 and raised its full year 2021 cash flow from operations guidance range to $13.0 billion to $13.5 billion from $12.5 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income